naloxone hydrochloride

Generic: naloxone hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naloxone hydrochloride
Generic Name naloxone hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form SPRAY
Routes
NASAL
Active Ingredients

naloxone hydrochloride 4 mg/.1mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1659
Product ID 51662-1659_19b0603b-2420-f439-e063-6294a90ae85f
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA211951
Listing Expiration 2026-12-31
Marketing Start 2023-07-30

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621659
Hyphenated Format 51662-1659

Supplemental Identifiers

RxCUI
1725059
UNII
F850569PQR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naloxone hydrochloride (source: ndc)
Generic Name naloxone hydrochloride (source: ndc)
Application Number ANDA211951 (source: ndc)
Routes
NASAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/.1mL
source: ndc
Packaging
  • 2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1659-2) / .1 mL in 1 VIAL, SINGLE-DOSE (51662-1659-1)
source: ndc

Packages (1)

Ingredients (1)

naloxone hydrochloride (4 mg/.1mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "19b0603b-2420-f439-e063-6294a90ae85f", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1725059"], "spl_set_id": ["19b0603b-241f-f439-e063-6294a90ae85f"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1659-2)  / .1 mL in 1 VIAL, SINGLE-DOSE (51662-1659-1)", "package_ndc": "51662-1659-2", "marketing_start_date": "20230730"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1659_19b0603b-2420-f439-e063-6294a90ae85f", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1659", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.1mL"}], "application_number": "ANDA211951", "marketing_category": "ANDA", "marketing_start_date": "20230730", "listing_expiration_date": "20261231"}